|
|
||||||||

* Department of Biochemistry, Juntendo University, School of Medicine, Tokyo, Japan; and
Koyo Chemical Co., Ltd., Tokyo, Japan
Correspondence: Isao Nagaoka, Department of Biochemistry, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. E-mail: nagaokai{at}med.juntendo.ac.jp
Glucosamine, an amino monosaccharide naturally occurring in the connective and cartilage tissues, contributes to maintaining the strength, flexibility, and elasticity of these tissues. In recent years, glucosamine has been used widely to treat osteoarthritis in humans and animal models. Neutrophils, which usually function as the primary defenders in bacterial infections, are also implicated in the destructive, inflammatory responses in arthritis. In this study, we have evaluated the effects of glucosamine on neutrophil functions using human peripheral blood neutrophils. Glucosamine (0.011 mM) dose-dependently suppressed the superoxide anion generation induced by formyl-Met-Leu-Phe (fMLP) or complement-opsonized zymosan and inhibited the phagocytosis of complement-opsonized zymosan or IgG-opsonized latex particles. Furthermore, glucosamine inhibited the release of granule enzyme lysozyme from phagocytosing neutrophils and suppressed neutrophil chemotaxis toward zymosan-activated serum. In addition, glucosamine inhibited fMLP-induced up-regulation of CD11b significantly, polymerization of actin, and phosphorylation of p38 mitogen-activated protein kinase (MAPK). In contrast, N-acetyl-glucosamine, an analogue of glucosamine, did not affect these neutrophil functions (superoxide generation, phagocytosis, granule enzyme release, chemotaxis, CD11b expression, actin polymerization, and p38 MAPK phosphorylation) at the concentrations examined (110 mM). Together these observations likely suggest that glucosamine suppresses the neutrophil functions, thereby possibly exhibiting anti-inflammatory actions in arthritis.
Key Words: superoxide phagocytosis chemotaxis F-actin p38 mitogen-activated protein kinase
This article has been cited by other articles:
![]() |
D. Xing, W. Feng, L. G. Not, A. P. Miller, Y. Zhang, Y.-F. Chen, E. Majid-Hassan, J. C. Chatham, and S. Oparil Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H335 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakayama, F. Yoshizaki, A. Prinetti, S. Sonnino, L. Mauri, K. Takamori, H. Ogawa, and K. Iwabuchi Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms J. Leukoc. Biol., March 1, 2008; 83(3): 728 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
B A Biggee, C M Blinn, T E McAlindon, M Nuite, and J E Silbert Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness Ann Rheum Dis, February 1, 2006; 65(2): 222 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Chou, N. Vergnolle, J. J. McDougall, J. L. Wallace, S. Marty, V. Teskey, and A. G. Buret Effects of Chondroitin and Glucosamine Sulfate in a Dietary Bar Formulation on Inflammation, Interleukin-1{beta}, Matrix Metalloprotease-9, and Cartilage Damage in Arthritis Experimental Biology and Medicine, April 1, 2005; 230(4): 255 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gomez-Cambronero, J. Horn, C. C. Paul, and M. A. Baumann Granulocyte-Macrophage Colony-Stimulating Factor Is a Chemoattractant Cytokine for Human Neutrophils: Involvement of the Ribosomal p70 S6 Kinase Signaling Pathway J. Immunol., December 15, 2003; 171(12): 6846 - 6855. [Abstract] [Full Text] [PDF] |
||||
![]() |
Is glucosamine worth taking for osteoarthritis? DTB, November 1, 2002; 40(11): 81 - 83. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |